Randomized Trial of Tenofovir Versus Lamivudine Plus Adefovir in Lamivudine Plus Adefovir Treated Lamivudine-resistant Chronic Hepatitis B Patients With Undetectable Hepatitis B Virus DNA.
Phase of Trial: Phase IV
Latest Information Update: 10 May 2017
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Adefovir dipivoxil; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 27 Oct 2016 Status changed from active, no longer recruiting to completed.
- 15 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 Apr 2016, according to ClinicalTrials.gov record.
- 15 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.